Fundamental dimension Equity attribute | CRBPPeer $4.05▼-1.94% Cap $78.33MP/E -0.6x QuantScore42/100 | ALECPeer $1.830.00% Cap $204.3MP/E -1.7x QuantScore39/100 | APLTLeader $0.103▲+0.00% Cap $14.86MP/E -0.4x QuantScore45/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
45/100 |
36/100 |
49/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 33/100 | 50/100 |
Health Piotroski, Altman Z, leverage & liquidity | 50/100 | 50/100 | 27/100 |
Growth Revenue / earnings growth & margins | 0/100 | 20/100 | 34/100 |
Sentiment Analyst ratings, targets & revisions | 82/100 | 58/100 | 63/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.6x | -1.7x | -0.4x |
Forward P/E (next FY) | -0.7x | -4.8x | -0.2x |
EV / EBITDA (TTM) | -0.6x | -1.6x | -0.1x |
Price / Sales | — | 14.7x | 14.9x |
Price / Free Cash Flow | -0.9x | -1.3x | -0.4x |
PEG ratio | 0.02 | 0.24 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 2 / 9 | 1 / 9 |
Altman Z-Score | -6.55 (Distress) | -7.43 (Distress) | -27.42 (Distress) |
Total debt / equity | 0.04 | -3.29 | -4.46 |
Quick ratio | 5.7x | 5.3x | 1.0x |
Interest coverage | — | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | -79.1% | -95.4% |
Net income growth YoY | -95.3% | -20.1% | +11.8% |
Gross margin (TTM) | 0.0% | 100.0% | -892.3% |
Operating margin (FY) | — | -692.8% | -22922.9% |
FCF margin (FY) | — | -874.7% | -18528.6% |
5. Trailing price performancePrice change over period |
1M return | -45.6% | -4.7% | 0.0% |
3M return | -55.8% | +23.6% | 0.0% |
6M return | -59.7% | -24.1% | 0.0% |
Year to date | -50.2% | +17.3% | +3.0% |
1Y return | -76.0% | +22.0% | -89.9% |
3Y return | -30.4% | -65.3% | -95.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $1.97 -51.3% premium | $-0.1693 -109.3% premium | $0.5295 +414.1% upside |
Wall Street consensus target | $33.67 +731.4% · range $33.00–$35.00 | $2.25 +23.0% · range $1.50–$3.00 | $2.13 +1968.0% · range $0.25–$4.00 |
Consensus stance | 88% Buy13% Hold0% Sell | 64% Buy21% Hold14% Sell | 45% Buy45% Hold9% Sell |